Molecular Pharmacology Program
The Jan Grimm Lab
Research

The Grimm lab in the Molecular Pharmacology Program focuses on the development of novel and innovative approaches for cancer diagnostics and therapy. These approaches evaluate underlying biology and utilize nanotechnology, chemistry and physics interrogated with modern imaging methods. The lab focuses currently several avenues: (i) the utilization of nanoparticles for cancer therapy; (ii) novel imaging approaches such as Cerenkov and optoacoustic imaging and (iii) the biology of PSMA both in prostate cancer and neovasculature using a tumor-on-chip microfluidic chip system.
Research Projects

Featured News



Publications
Quo Vadis, Molecular Imaging? Grimm J, Kiessling F, Pichler BJ. J Nucl Med. 2020 Oct;61(10):1428-1434. doi: 10.2967/jnumed.120.241984. Epub 2020 Aug 28. PMID: 32859706.
Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring.Pratt EC, Isaac E, Stater EP, Yang G, Ouerfelli O, Pillarsetty N, Grimm J. J Nucl Med. 2020 Dec;61(12):1845-1850. doi: 10.2967/jnumed.120.241901. Epub 2020 May 22. PMID: 32444378.
People

Jan Grimm, MD, PhD
- Radiologist and Nuclear Medicine physician Jan Grimm develops novel approaches for improved diagnosis, monitoring and therapy of prostate and other cancers.
- MD, University of Hamburg (Germany)
- PhD, University of Kiel (Germany)
- [email protected]
- Email Address
- 646-888-3095
- Office Phone
- Download CV
- PDF File
- View physician profile
- Physician profile
Members

- Radiologist




Member/Professor

Senior Research Assistant

Graduate Student - Cornell Pharmacology
Senior Administrative Assistant

Senior Research Technician

Graduate Student- Cornell Pharmacology
NE Student

Research Scholar

Research Technician

Graduate Student- Cornell Pharmacology

Research Associate

Postdoctoral Scholar

Postdoctoral Researcher
Research Fellow

Graduate Student- Hunter College

- Dublin City University (Physical Chemistry)

- Material Science and Moelcular Biology
- 646-888-3101
- Lab Phone

- PhD at UPenn



- Training in Urology

- PhD in Chemistry, Georgtown University
- 646-888-3101
- Lab Phone

- PhD in biology, University Hospital Jena, Germany

- University of Koeln, Germany

- PhD in Immunology, State University of Campinas-UNICAMP
- 646-888-3101
- Lab Phone



Lab Alumni

Research Fellow

Research Fellow

Research Fellow

Research Fellow

Graduate Student

Administrative Assistant

Visiting Scientist

Research Fellow

Research Scholar

Research Scholar

Research Fellow

Research Fellow
Senior Research Scientist

Administrative Assistant

Research Fellow


Graduate Research Assistant
Lab Affiliations
Achievements
- 2014- NIH Nagy New Investigator Award
- 2018- The American Society for Clinical Investigation (ASCI) Member
Get in Touch
-
Lab Head Email
-
Office Phone
-
Office Fax
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jan Grimm discloses the following relationships and financial interests:
-
Gerson Lehrman Group
Professional Services and Activities
-
Society of Nuclear Medicine and Molecular Imaging
Professional Services and Activities
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].